Isavuconazole an attractive antifungal prophylactic in acute myeloid leukaemia/myelodysplastic syndrome
Isavuconazole, an extended spectrum mold-active triazole, is safe and effective as primary antifungal prophylaxis in patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome undergoing remission-induction chemotherapy, according to the results of a phase II study.
